Replication Timing Profiles for Leukemia Diagnosis
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current biomarkers for cancer, such as chromosome abnormalities and gene expression tests, are only partially effective in diagnosis and do not comprehensively address the misregulation of replication timing in cancer cells.
Innovation Solution
Determining the type of leukemia by analyzing replication timing profiles using a computer-based method that generates genome-wide replication-timing fingerprints, which can distinguish between leukemic and non-leukemic cells and identify specific epigenetic markers.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If current biomarkers (chromosome abnormalities and gene expression tests) are used for cancer diagnosis, then diagnosis can be performed, but the diagnostic effectiveness is only partial and does not comprehensively address replication timing misregulation
Solution Approach 1:
The patent applies universality by developing a replication timing profile analysis method that can diagnose multiple types of leukemia and potentially other cancers through a single comprehensive approach. The method analyzes replication timing across the entire genome, providing a universal diagnostic tool that addresses both the precision and comprehensive coverage needs of cancer diagnosis.
Solution Approach 2:
The patent introduces a new dimension to cancer diagnosis by analyzing replication timing profiles, which is a temporal dimension not captured by traditional chromosome abnormality or gene expression tests. This adds a fourth dimension (temporal replication timing) to the traditional three-dimensional diagnostic approach (chromosome structure, gene expression levels, and cellular morphology), enabling more comprehensive cancer characterization.
2Loss of information
If traditional biomarker tests are used, then diagnosis can be performed, but they fail to identify epigenetic markers and sites of abnormal developmental control
Solution Approach 1:
The patent replaces traditional mechanical and chemical diagnostic methods (chromosome staining, gene expression assays) with a computational approach that analyzes replication timing profiles. This substitution enables the extraction of epigenetic information through bioinformatics analysis of replication timing data, recovering information that was previously inaccessible through conventional methods.
3Measurement precision
If replication timing profiles are analyzed to identify leukemia types, then accurate identification and epigenetic biomarker discovery are achieved, but the method requires genome-wide analysis
Solution Approach 1:
The patent applies segmentation by dividing the genome into manageable regions and analyzing replication timing profiles in a systematic manner. The method segments the complex genome-wide data into analyzable units, allowing for precise leukemia type identification while managing the complexity through structured data organization and computational analysis.
Data Source
AI summary
Described is a method for determining that a population of cells are a specific type of leukemic cell based on the replication timing fingerprint for the population of cells.